MYCIO Wealth Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

MYCIO Wealth Partners’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,500	Closed	-$102K	–	236
2016 Q3	$102K	Hold	1,500	–	–	0.02%	257
2016 Q2	$83K	Hold	1,500	–	–	0.01%	283
2016 Q1	$94K	Buy	1,500 +300	+25%	+$19.9K	0.02%	247
2015 Q4	$113K	Buy	1,200 +200	+20%	+$18.5K	0.02%	202
2015 Q3	$80K	Hold	1,000	–	–	0.02%	239
2015 Q2	$120K	Buy	1,000 +400	+67%	+$47.8K	0.02%	189
2015 Q1	$63K	Buy	+600	New	+$60.8K	0.01%	260
2014 Q3	–	Sell	-500	Closed	-$32K	–	618
2014 Q2	$32K	Hold	500	–	–	0.01%	321
2014 Q1	$34K	Hold	500	–	–	0.01%	298
2013 Q4	$32K	Buy	500 +250	+100%	+$14.9K	0.01%	297
2013 Q3	$16K	Buy	+250	New	+$12.5K	﹤0.01%	350

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MYCIO Wealth Partners's ALNY Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2016, closing a stake of 1,500 shares — an estimated $102K sold.

MYCIO Wealth Partners first reported a position in ALNY in Q3 2013 and held it in 11 quarters. The position peaked at $120K in Q2 2015. 211 funds tracked by Wall St. Rank hold ALNY as of Q4 2016.

MYCIO Wealth Partners reported no remaining Alnylam Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
MYCIO Wealth Partners sold 1,500 Alnylam Pharmaceuticals shares in Q4 2016, an estimated $102K.
MYCIO Wealth Partners first reported a position in Alnylam Pharmaceuticals in Q3 2013 and held it in 11 quarters.
MYCIO Wealth Partners's Alnylam Pharmaceuticals position peaked at $120K in Q2 2015.
211 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.